These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 22689131)
1. Seronegative myasthenia gravis: the importance of clusters of acetylcholine receptors. Rowland LP Arch Neurol; 2012 Aug; 69(8):965-6. PubMed ID: 22689131 [No Abstract] [Full Text] [Related]
2. Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis. Lee I; Sanders D Muscle Nerve; 2021 Oct; 64(4):385-387. PubMed ID: 34287983 [No Abstract] [Full Text] [Related]
3. A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association? Filippelli E; Barone S; Granata A; Nisticò R; Valentino P Neurol Sci; 2019 Jan; 40(1):195-197. PubMed ID: 30215155 [No Abstract] [Full Text] [Related]
4. 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies. Evoli A; Alboini PE; Damato V; Iorio R Neurology; 2016 Mar; 86(11):1070-1. PubMed ID: 26873957 [No Abstract] [Full Text] [Related]
5. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. Rajakulendran S; Viegas S; Spillane J; Howard RS J Neurol; 2012 Dec; 259(12):2736-9. PubMed ID: 22955633 [No Abstract] [Full Text] [Related]
6. Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis? Sanders DB; Burns TM; Cutter GR; Massey JM; Juel VC; Hobson-Webb L; Muscle Nerve; 2014 Apr; 49(4):483-6. PubMed ID: 23835683 [TBL] [Abstract][Full Text] [Related]
7. MuSK antibody positive myasthenia gravis in a 38-year old West Indian female. Ramcharan K; Bahall M; Bodoe C; Khan S; Ewe P; Sharma S West Indian Med J; 2011 Dec; 60(6):694-5. PubMed ID: 22512235 [No Abstract] [Full Text] [Related]
8. Reduced plasmablast frequency is associated with seronegative myasthenia gravis. Guptill JT; Barfield R; Chan C; Russo MA; Emmett D; Raja S; Massey JM; Juel VC; Hobson-Webb LD; Gable KL; Gonzalez N; Hammett A; Howard JF; Chopra M; Kaminski HJ; Siddiqi ZA; Migdal M; Yi JS Muscle Nerve; 2021 Apr; 63(4):577-585. PubMed ID: 33294984 [TBL] [Abstract][Full Text] [Related]
9. Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. Jacob S; Viegas S; Leite MI; Webster R; Cossins J; Kennett R; Hilton-Jones D; Morgan BP; Vincent A Arch Neurol; 2012 Aug; 69(8):994-1001. PubMed ID: 22689047 [TBL] [Abstract][Full Text] [Related]
10. An update on laboratory diagnosis in myasthenia gravis. Oger J; Frykman H Clin Chim Acta; 2015 Sep; 449():43-8. PubMed ID: 26238187 [TBL] [Abstract][Full Text] [Related]
15. [Antibodies to acetylcholine receptor in patients with different clinical forms of myasthenia and Lambert-Eaton myasthenic syndrome]. Sidnev DV; Karganov MIu; Shcherbakova NI; Alchinova IB; Sanadze AG Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):53-5. PubMed ID: 16457135 [No Abstract] [Full Text] [Related]
16. Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive thymoma. Ishikawa H; Taniguchi A; Ii Y; Higuchi O; Matsuo H; Nakane S; Asahi M; Niwa A; Tomimoto H Neuromuscul Disord; 2017 Oct; 27(10):914-917. PubMed ID: 28694075 [TBL] [Abstract][Full Text] [Related]